The Cancer Consortium provides a variety of funding opportunities for the purpose of supporting existing members and recruiting new ones, with the ultimate goal of stimulating innovative cancer research. Opportunities include Pilot Awards, New Investigator Awards, and Catchment Area Health Pilot Awards.
Consortium developmental awards are funded through a combination of Cancer Center Support Grant (CCSG) funds and philanthropic donations. Applications for each award are evaluated by a committee of Consortium faculty reviewers.
Eligibility and application requirements are different for each award. For more information, please review the description and RFA for each individual award.
Consortium members are automatically notified of new funding opportunities, including CCSG administrative supplements. If you are not a member and would like to stay informed about current funding opportunities, please email firstname.lastname@example.org to be added to the Consortium newsletter.
Funds are available from the Fred Hutch/University of Washington Cancer Consortium (“The Consortium”) Cancer Center Support Grant (CCSG) to support cancer-related pilot projects. This competition will provide awards of up to $100,000 direct costs (plus F&A/indrect costs as allowable) for one year of pilot project support.
- Consortium members are eligible for this pilot funding (see Application Process in RFA for more details).
- There are no limitations on research topic, as long as the problem under study is focused on cancer. Highly innovative concepts that have the potential to improve the lives of cancer patients are encouraged. Also included in this competition are two categories targeted as areas of special interest to the Consortium: Health Disparities research and Cross-Disciplinary Translational research.
Release date — January 4, 2023
Due date — February 27, 2023
Funds are available from the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium ("The Consortium") Cancer Center Support Grant (CCSG) to provide developmental support to new or junior faculty who are establishing their research within the Consortium. These funds provide a flexible source of funding designed to allow new investigators to work toward obtaining future, independent research funding. Departments are also eligible to apply for this funding to support new faculty being hired by a Consortium institution.
This competition will provide four to five awards of up to $100,000 direct costs each (plus F&A/indirect costs). One award will be reserved for a faculty member sho identifies as belonging to a group that is underrepresented in the biomedical, clinical, behavioral, and social sciences, as defined by the NIH.
In order to be eligible for this award, applicants must meet one or more of the following requirements:
- Consortium members or those eligible to become a member at the time of award. Membership criteria are detailed on the Consortium website: http://www.cancerconsortium.org/en/membership.html.
- Assistant Professor level or higher who have begun their appointment at one of the Consortium institutions (Fred Hutch, University of Washington, Seattle Children’s) on or after July of 2020.
- New faculty being recruited who will meet Consortium membership criteria at the time of the award start date.
Faculty who meet the following criteria are NOT eligible for this award:
- Faculty who have received a CCSG-funded award of any kind OR a pilot award funded by Safeway or the Hite Foundation within three years of the application deadline (since June 2020).
- Investigators who are PIs on R01, P01, or P50 grants.
- Consortium members in Acting faculty positions and faculty with Consortium Affiliate memberships.
All research proposals must be cancer-focused. Financial need will be taken into consideration for those who did not receive substantial research funds as part of their negotiatied start-up package.
Release date: May 1, 2023
Due date: June 16, 2023, by 5:00pm
For additional information and detailed application instructionss, please see the attached RFA:
Request for Applications – 2023 Cancer Consortium New Investigator Awards
Applications are to be submitted using InfoReady. To access the application, click here.
Funds are available from the Fred Hutch/University of Washington Cancer Consortium (Consortium)’s Cancer Center Support Grant (CCSG) and non-sponsored funds to support new cancer-related pilot projects or research directions focused on the Consortium’s catchment area, which now includes the entire state of Washington. Please see page 1 of RFA for more information about the cancer burden in the catchment area.
The research plan should address research on cancers relevant to the catchment area and/or the populations that face the highest burden or cancer disparities in the state. Please see pages 1-2 of the RFA. This competition will fund at least one project, at a minimum of $80,000 in direct costs, for one year.
Consortium members are eligible for this pilot funding. Only one Principal Investigator applicant per Cancer Consortium Research Program will be accepted (see section “B. Application Format – Page limits and attachments #1” for more details).
Release date — January 19, 2023
Due date — February 28, 2023
To apply, please submit the PDF file containing your application (included in the RFA) and letter of support to to the Office of Community Outreach & Engagement via e-mail at EndDisparities@fredhutch.org.
Funds are available from Safeway, Inc. to support cancer-related pilot projects with awards of at least $80,000 direct costs (F&A not included) for one year of pilot project support. Fred Hutch early career investigators who are Consortium members are eligible for this funding opportunity.
There are no limitations on research topic, as long as the problem under study is focused on cancer. Highly innovative concepts that have the potential to improve the lives of cancer patients are encouraged.
- Fred Hutch early career investigators who are Consortium members are eligible for this funding opportunity. Information and instructions on how to join the Cancer Consortium can be found here.
- There are no limitations on research topic, as long as the problem under study is focused on cancer. Highly innovative concepts that have the potential to improve the lives of cancer patients are encouraged.
More details about the application process can be found in the RFA.
Release date — September 26, 2022
Due date — October 21, 2022 at 5 pm
Applications are to be submitted as one complete PDF file to: email@example.com
The Survivorship Program invites proposals of high impact and innovation that will promote new research directions focused on cancer survivors. The goal of this award is to stimulate cross-institutional collaborations (Fred Hutch, University of Washington, Seattle Children’s) and/or new collaborations between Consortium investigators who have not previously worked together.